Selective estrogen receptor modulators like tamoxifen or raloxifene have been tried in the treatment of endometriosis [54] based on observations that SERMs may reduce endometriosis lesion in mouse [55]; however, their value in the treatment of adenomyoma has not been formally explored. Here, ESR1 is linked to adenomyoma.